Tenascin-C is an adhesion-modulatory extracellular matrix protein that is predominantly expressed during embryonic development, wound healing and in tumor stroma. Here we report that anchorage-dependent human, rat and mouse fibroblasts adhere poorly and fail to proliferate on pure tenascin-C. This was due to a significant reduction of cyclin-dependent kinase 2 (cdk2) activity, resulting from elevated expression and association of the cdk inhibitors (CKIs) p21Cip1 and p27Kip1. To analyse the effect of tenascin-C on fibronectinmediated adhesion, cells were plated on a mixed fibronectin/tenascin-C substratum. Compared to fibronectin alone, cell spreading and adhesion signaling were compromised, as determined by delayed phosphorylation kinetics of focal adhesion kinase (FAK). Despite the presence of growth factors, these cells remained arrested in the G1 phase of the cell cycle. In contrast to cells plated on pure tenascin-C, cdk2 activity appeared to be inhibited independently of CKIs. Interestingly, overexpression of the transmembrane proteoglycan syndecan-4 restored cell spreading, adhesion signaling and DNA replication on the fibronectin/tenascin-C substratum. A similar rescue was observed using a recombinant peptide that spans the syndecan-4-binding site in fibronectin. This indicates that tenascin-C causes cell cycle arrest and cdk2 inactivation by interfering with fibronectin-syndecan-4 interactions. We therefore propose that syndecan-4 signaling plays a central role in the control of cellular proliferation of anchorage-dependent fibroblasts.
Introduction
Many animal models in which either an extracellular matrix (ECM) molecule or its receptor have been disrupted (reviewed in Hynes, 1994; De Arcangelis and Georges-Labouesse, 2000) are embryonically lethal, suggesting that cell adhesion to the ECM is essential for embryonic development. In vivo, cells exist in contact with structurally distinct ECMs that can contain both adhesive and antiadhesive molecules such as fibronectin and tenascin-C, respectively (reviewed in Gould et al., 1990) . Most normal cells adhere, spread and replicate when plated on the adhesive ECM molecule fibronectin. Fibronectin plays a critical role during development; for example, fibronectin-deficient mice die at E10/11 (reviewed in Hynes, 1994) . In contrast, tenascin-C is an antiadhesive ECM molecule that modulates the adhesive functions of fibronectin (Chiquet-Ehrismann et al., 1986) . Tenascin-C is expressed at cellular borders where epithelial mesenchymal transitions occur (Ekblom and Aufderheide, 1989) and around growing and budding mammary (Young et al., 1994) and lung epithelia (Kalembey et al., 1997) . It is highly expressed during morphogenesis in connective tissue and the vasculature, as well as in tumor stroma (reviewed in Vollmer, 1997) .
Both stimulatory and inhibitory effects of tenascin-C on cell proliferation have been reported. Whether anchorage-dependent cells proliferate in the presence of tenascin-C depends on the experimental conditions, for example, on the cell type and method of exposure to tenascin-C (reviewed in Orend and Chiquet-Ehrismann, 2000) . In addition, tenascin-C harbors interaction sites for a variety of cell surface receptors that may be differentially expressed in cells of different origin (reviewed in Vollmer, 1997) . The effects on cell spreading and cell proliferation are even more complex when cells are plated on mixed substrata containing additional ECM components, which may resemble in vivo conditions more closely. For example, proliferation of human smooth muscle cells appears to be enhanced in collagen gels containing tenascin-C (Jones et al., 1997) . Similarly, in oligodendrocytes from tenascin-C-deficient mice, survival and proliferation decreases, suggesting a proliferation-stimulatory role of tenascin-C on these cells during development (Garcion et al., 2001) . Finally, rat mammary adenocarcinoma (Chiquet-Ehrismann et al., 1986) and human tumor cell lines, including glioblastoma and breast carcinoma are growth stimulated on a mixed fibronectin/tenascin-C substratum. However, in none of the reported cases has the effect on the cell cycle machinery been addressed.
Initiation of cell division involves the integration of several external stimuli that converge on the cell cycle machinery. Cell cycle progression relies on the orchestrated action of cyclin-dependent kinases (cdks). Passage through G1 is mediated by sequential activation of cyclin D-dependent cdk4 and cdk6 and cyclin Edependent cdk2. The activity of these cdks is negatively regulated by binding of specific cdk inhibitors (CKI), belonging to either the INK4 or the CIP/KIP family of proteins (Assoian, 1997) . Proliferation of most untransformed cells is anchorage dependent and cells become arrested in the G1 phase of the cell cycle when kept in suspension culture. Several underlying mechanisms have been described, including downregulation of cyclin D expression and the inactivation of cdk2 complexes through the CKIs p21Cip1 and p27Kip1 (reviewed in Assoian, 1997; Miranti and Brugge, 2002) . Here we examine how tenascin-C alone and in combination with fibronectin affects proliferation of anchorage-dependent cells.
Results

Tenascin-C is antiadhesive for anchorage-dependent fibroblasts and compromises DNA replication
We analysed adhesion and G1/S cell cycle progression of several anchorage-dependent normal human fibroblasts (HDF, HS68, MRC-5), immortal REF52 rat embryo fibroblasts and NIH3T3 cells plated under defined medium conditions on tenascin-C and fibronectin. Cells were serum starved, trypsinized and replated on tenascin-C, fibronectin and BSA or agar in the absence of growth factors. As seen for other cells (ChiquetEhrismann et al., 1986) all fibroblasts tested were compromised in cell adhesion by tenascin-C to an extent similar to that by anti-adhesive BSA (data not shown).
Normal human fibroblasts are anchorage dependent and require attachment to an adhesive and permissive ECM to pass the G1/S restriction point (reviewed in Assoian, 1997) . Since normal fibroblasts failed to adhere on tenascin-C but did not show signs of apoptosis (data not shown); we investigated whether the cells were blocked in their cell cycle progression. Indeed, growthfactor-induced DNA replication was inhibited in all fibroblast lines to levels similar to those on antiadhesive agar (Table 1) or BSA (data not shown). Measuring DNA replication of attached and floating cells separately confirmed that none of the cells incorporated significant amounts of [ 3 H]thymidine on the tenascin-C substratum (Table 1) .
A tenascin-C substratum blocks cyclin E-cdk2 activity by increasing the expression levels of the CKIs p21Cip1 and p27Kip1 without inhibiting cyclin D-cdk4
In human diploid fibroblast (HDF) cells, detachment can cause inactivation of cyclin E-cdk2 due to increased levels of the CKIs p21Cip1 and p27Kip1 (Fang et al., 1996) . Therefore, we analysed the activity of cyclin Ecdk2 and the expression levels of these CKIs in cells detached by tenascin-C. As shown in an in vitro histone H1 kinase assay, cdk2 activity in HDF cells was blocked to a similar extent when plated on tenascin-C, or BSA, an artificial antiadhesive reference substratum. This effect contrasts with cells plated on fibronectin, where the complex was highly active (Figure 1a ). Decreased cdk2 activity in HDF cells plated on tenascin-C was not due to reduced expression of cdk2 itself or cyclin E (Figure 1b) . In S phase, cdk2 also associates with cyclin A. In agreement with a G1 arrest, cyclin A was not detected in HDF cells plated on tenascin-C or BSA (Figure 1b) . Thus, the cdk2 activity measured in HDF cells can be attributed to the cyclin E-cdk2 complex.
In HDF cells plated on tenascin-C, the expression levels of p21Cip1 and p27Kip1 were several fold higher on fibronectin (Figure 1b) . Similar results were obtained for REF52 and MRC-5 cells (data not shown). Moreover, we also observed an increased association of these inhibitors with cdk2 in MRC-5 ( Figure 1c) and cyclin E and cdk2 in REF52 (data not shown), which provides an explanation for the inactivation of cyclin E-cdk2. To investigate the potential inactivation of cyclin E-cdk2 by tenascin-C due to reduced cyclin D-cdk4 activity, we determined the expression and activity of cyclin D-cdk4 in cells plated on tenascin-C and fibronectin. Neither cdk4 nor cyclin D expression levels were reduced in HDF cells plated on tenascin-C compared with fibronectin ( Figure 1d ). Identical observations were made for REF52 (data not shown). In addition, cdk4 immunoprecipitates from HDF cells were as active in an in vitro RB kinase assay as those from lysates of cells plated on fibronectin (Figure 1e ). This shows that cyclin E-cdk2 inactivation was not due to decreased cyclin D-cdk4 activity.
Taken together, our results indicate that the mechanism underlying the observed G1/S block on a pure tenascin-C substratum is similar to the one described for anchorage-dependent fibroblasts that are prevented from attachment (Fang et al., 1996; Zhu et al., 1996;  Kuzumaki and Ishikawa, 1997) , namely the inactivation of cyclin E-cdk2 by increased levels of the CKIs p21Cip1 and p27Kip1.
Tenascin-C interferes with cell spreading and adhesion signaling on fibronectin and blocks cell proliferation Both fibronectin (Hynes, 1994) and tenascin-C (Mackie and Tucker, 1999) play a role in embryonic development and tenascin-C and fibronectin are often coexpressed (Chiquet-Ehrismann et al., 1986) . As mentioned above, tenascin-C interferes with cell adhesion on fibronectin (Chiquet-Ehrismann et al., 1988; Hauzenberger et al., 1999; Huang et al., 2001) . To test whether tenascin-C modulates cell adhesion and proliferation of normal fibroblasts in a fibronectin context, we plated cells on a mixed substratum of fibronectin and tenascin-C. Phalloidin staining revealed that cell spreading was markedly disturbed in REF52 cells 1 h after plating on the mixed substratum ( Figure Figure 2b ). The a5b1 integrin as the major fibronectin receptor is recruited into focal adhesions upon spreading on fibronectin. By immunofluorescence with a b1 integrin-specific antibody, we found b1 integrins to be diffusely dispersed in cells on the mixed substratum. This is in contrast to the localization of b1 integrins to focal adhesions in cells plated on fibronectin (Figure 2c ). Upon integrinmediated adhesion to fibronectin, intracellular signaling is initiated which involves recruitment of paxillin and FAK into newly generated focal adhesions (reviewed in van der Flier and Sonnenberg, 2001 ). Since focal adhesion formation was largely disturbed on the mixed substratum ( Figure 2b , c), we analysed the localization of paxillin and FAK. Similar to vinculin and b1 integrins paxillin and FAK were found to be dispersed over the cell body on the fibronectin/tenascin-C substratum. This is in contrast to cells plated on fibronectin in which paxillin and FAK were present in focal adhesions (Figure 2d , e). Since recruitment into focal adhesions is a prerequisite for FAK and paxillin activation by phosphorylation (Turner, 1994; Schlaepfer et al., 1999) , we predicted that these molecules were not activated on the fibronectin/tenascin-C substratum. Indeed, FAK was highly phosphorylated 45 min after plating on fibronectin, however remained largely unphosphorylated on the mixed substratum ( Figure 2f ). This appeared to be mainly due to a lack of FAK autophosphorylation on Y397 (Figure 2f ), suggesting that a very early step in adhesion signaling is blocked on the mixed substratum. Although REF52 cells were partially spread after 3 (not shown) and 4 h ( The establishment of focal adhesions, actin stress fibers and the activation of associated cytoplasmic signaling including FAK phosphorylation is known to be required for cell cycle progression of anchoragedependent cells into S phase (reviewed in Giancotti and Ruoslahti, 1999) . Therefore, we analysed whether DNA replication was also inhibited on the mixed substratum. Indeed, [
3 H]thymidine incorporation in serum-starved NIH3T3, REF52, HDF, MRC-5 and MRC-5 SV40 cells (Table 2a ) plated in growth-factor-containing medium onto a fibronectin/tenascin-C substratum revealed that DNA synthesis was reduced to levels as low as on the artificial antiadhesive reference substratum BSA (Table  2a , and data not shown). Not only serum-starved synchronized cells but also asynchronously growing MRC-5 cells were blocked in DNA replication on the mixed substratum (Table 2a ), indicating that tenascin-C blocks cells in G1 phase, rather than preventing synchronized cells from leaving the G1 phase. This possibility was also supported by FACS analysis showing that 87% of REF52 cells were arrested in the G1 phase on the fibronectin/tenascin-C substratum, Figure 1 Activity of cdk2 and cdk4, expression levels of cell cycle molecules and association of CKIs with cyclin E-cdk2 on tenascin-C. Cdk2 was immunoprecipitated from HDF cells 18 h after plating the cells on fibronectin, tenascin-C or BSA in the presence of 80 ng/ ml PDGF-BB. WRS serum immunoprecipitation served as control (C). Cdk2-associated kinase activity was measured by in vitro phosphorylation of histone H1 (a). Serum-starved cells were plated on fibronectin, tenascin-C or BSA in the presence of PDGF-BB. Cells were lysed 22 h after plating. Equal amounts of protein were separated by 4-20% PAGE and immunoblotted as indicated (b). Cdk2 was immunoprecipitated from MRC-5 lysates and immunoblotted for associated p21Cip1 and p27Kip1 (c). Lysates from HDF cells were prepared 7 h after plating on fibronectin or tenascin-C (d, e). Equal amounts of protein were immunoprecipitated with an anti-cdk4 antibody followed by an in vitro RB-kinase assay (e) or separated by 4-20% PAGE and immunoblotted for cyclin D and cdk4 (d)
Tenascin-C blocks syndecan-4 and inhibits cdk2 G Orend et al which is in contrast to cells grown on fibronectin where 43% of cells resided in S and G2/M phases (Table 2b) . FACS analysis after 48 h of plating also revealed that cells did not die on the fibronectin/tenascin-C substratum, which was supported by intact nuclear morphology as seen by Hoechst staining (data not shown). Finally, decreased thymidine incorporation on the mixed substratum due to delayed initiation of DNA replication could be ruled out as no incorporation was detectable in REF52 cells labeled every 2 h starting 14.5 h after plating. In comparison, [
3 H]thymidine incorporation peaked at 18.5 h in cells on fibronectin (data not shown).
Decreased cdk2 activity on a mixed fibronectin/tenascin-C substratum
To investigate whether tenascin-C in combination with fibronectin blocks DNA replication by inactivation of cyclin E-cdk2, as observed for a pure tenascin-C substratum (Figure 1a) , we determined cdk2 activity in lysates from HDF cells plated on fibronectin/tenascin-C. Cdk2 activity in these cells was indeed downregulated compared to cells plated on fibronectin (Figure 3a) . Furthermore, the lack of high-mobility cdk2 in HDF, NIH3T3 and REF52 cells as determined by Western blotting was indicative of cdk2 inactivation (Figure 3b) . In contrast to a pure tenascin-C substratum where the CKI levels increased, neither expression of p21Cip1 and p27Kip1 in HDF (Figure 3c ) and NIH3T3 cells (data not shown) nor association of the CKIs with cdk2 (data not shown) were elevated. Again, inactivation of cyclin D-cdk4 could be excluded since cdk4 immunoprecipitates from HDF cells (Figure 3d) , and REF52 cells (not shown) plated on fibronectin/tenascin-C were as active in an in vitro RB kinase assay as those from lysates of cells plated on fibronectin. Furthermore, neither cdk4 Figure 2 Compromised cell spreading and adhesion signaling on a mixed fibronectin/tenascin-C substratum. REF52 (a, b, f) and MRC-5 (c, d, e) cells were plated on fibronectin and fibronectin/tenascin-C for the indicated time periods, fixed and stained with TRITC-phalloidin (a), and antibodies against vinculin (b), b1 integrin (c), paxillin (d) and FAK (e). Arrowheads point to actin stress fibers and focal adhesions in cells plated on fibronectin, and to lamellipodia and smaller focal complexes in cells plated on the mixed substratum. (e) Cells were lysed at the indicated time points, FAK was immunoprecipitated as indicated and detected with a phosphotyrosine specific (4G10) and a phospho-site-specific FAK antibody (Y379 FAK). Scale bars represent 25 mm nor cyclin D expression levels were altered (Figure 3e ). Identical observations were made for REF52 cells (not shown). In summary, on the fibronectin/tenascin-C substratum, the G1/S block does not appear to be regulated by an increase in the CKIs. b1 integrindependent adhesion on fibronectin was shown to cause downregulation of p27Kip1 (Hazlehurst et al., 2000) . Since ligation of b1 integrins is probably not compromised by tenascin-C (Chiquet-Ehrismann et al., 1988) this could provide an explanation for constant p27Kip1 levels on fibronectin/tenascin-C. Moreover, plating of smooth muscle cells on SPARC, another adhesion modulatory ECM molecule, also inhibited cdk2 independent of the CKIs (Motamed et al., 2002) . The CKIindependent mechanism by which cyclin E-cdk2 is inactivated on fibronectin/tenascin-C needs to be addressed in future experiments.
Activation of syndecan-4 restores cell spreading and proliferation on a mixed fibronectin/tenascin-C substratum Cell adhesion to fibronectin is mediated not only by integrins but also by heparan sulfate proteoglycans. These proteoglycans include the syndecan family of transmembrane receptors that bind to heparin-binding sites within fibronectin (reviewed in Bass and Humphries, 2002) . We have recently shown that syndecan-4 function is blocked by tenascin-C in a fibronectin context for tumor cells and that this function could be restored in tumor cells by either overexpression of syndecan-4 or by addition of FNIII13, a recombinant fragment that serves as syndecan-4-binding site in fibronectin ). To address a potential involvement of syndecan-4 in tenascin-C-mediated growth arrest in anchorage-dependent cells, we generated pools of REF52 cells stably overexpressing syndecan-4 ( Figure 4a ). As shown in Figure 4 activation of syndecan-4 through overexpression restored cell spreading on the mixed substratum to the degree observed on fibronectin. This included formation of actin stress fibers (Figure 4b ) and vinculin containing focal adhesions (Figure 4d ). This was specific to syndecan-4 since spreading of REF52 cells overexpressing syndecan-1 and -2 was not rescued (data not shown). A similar rescue could be achieved by the addition of FNIII13 to the fibronectin/tenascin-C substratum (Figure 4c, d ). To prove specificity and narrow down the activity within FNIII13, we tested pep I, a 20 amino-acid peptide (RRARVTDATETTI-TISWRTK) and pep II, a 10 amino-acid peptide (RRARVTDATE) (data not shown) present in FNIII13 that harbor 5 and 3 of the six critical basic amino acids for heparin binding in FNIII13 (Busby et al., 1995; Sharma et al., 1999) , respectively. The addition of these Result of a FACS analysis is shown for growth factor stimulated REF52 cells that were grown for 22 h on fibronectin (FN) and fibronectin/tenascin-C (FN/TN) Figure 3 Cdk2 and cdk4 activity and expression of cell cycle molecules on a mixed fibronectin/tenascin-C substratum. HDF (ae), NIH3T3 (b) and REF52 (b) cells were plated on the indicated substrata and histone H1 (a) RB kinase activity (d) and protein expression (b,c,e) were determined as described (cf. Figure 1) peptides to the fibronectin/tenascin-C substratum allowed REF52 cells to spread with the formation of actin stress fibers (Figure 4c ) and focal adhesions (data not shown). The spreading on the pep I containing triple component substratum was blocked by the addition of heparin, suggesting that pep I binds to syndecan-4 in a Tenascin-C blocks syndecan-4 and inhibits cdk2 G Orend et al glycosaminoglycan-dependent manner as we recently demonstrated for FNIII13 . Since adhesion was restored on the fibronectin/tenascin-C substratum upon activation of syndecan-4, we tested whether FAK phosphorylation was also rescued. Indeed, activation of syndecan-4 in REF:S4 cells fully restored autophosphorylation of FAK on the fibronectin/tenascin-C substratum while nonadherent cells on BSA lacked autophosphorylated FAK (Figure 4e ). Considering that diploid fibroblasts are dependent on cell adhesion to proliferate, we wanted to know whether syndecan-4 activation restored cell proliferation on a fibronectin/tenascin-C substratum. Indeed, on a mixed substratum, DNA replication of REF:S4 cells was rescued compared to parental cells and reached 65% of the replication on a fibronectin substratum (Figure 4f ). Additional activation of overexpressed syndecan-4 with FNIII13 further increased DNA replication to 77% of that seen on fibronectin (Figure 4f ).
Discussion
In this study, we investigated how tenascin-C affects cell cycle progression of anchorage-dependent cells. We observed that on a pure tenascin-C substratum normal fibroblasts are blocked in G1/S. Our data suggest that the underlying mechanism is similar to the one described for anchorage-dependent fibroblasts that are prevented from attachment (reviewed in Assoian, 1997) , namely the inactivation of cyclin E-cdk2 by increased levels of the CKIs p21Cip1 and p27Kip1. This mechanism may be of biological relevance in developing tissues with high tenascin-C expression levels (Chiquet-Ehrismann et al., 1986) . In support of this possibility, increased CKI levels have been found during differentiation of myoblasts (Parker et al., 1995; Missero et al., 1995) , oligodendrocytes (Levine et al., 2000) , placental trophoblasts (Zhang et al., 1998) and mammary epithelial cells (Muraoka et al., 2001) , tissues that are documented to express tenascin-C. We suggest that, under certain conditions, tenascin-C is involved during embryonic development in terminal differentiation through its cell-cycle-arresting effect. In addition, tenascin-C may act to check cell proliferation in actively remodeling tissues, thereby allowing reestablishment of tissue homeostasis after a phase of proliferation.
We further demonstrate that on a fibronectin/ tenascin-C substratum spreading of anchorage-dependent cells is compromised, as detected by a defect in focal adhesion formation and FAK activation. We have previously shown that in tumor cells tenascin-C blocks syndecan-4 through competitive binding to FNIII13, the syndecan-4 binding site in fibronectin . Now, we show that spreading and focal adhesion formation can be restored in anchorage-dependent fibroblasts upon activation of syndecan-4 through overexpression and ligation with FNIII13. In addition, activation of syndecan-4 restores FAK phosphorylation on the fibronectin/tenascin-C substratum not only in tumor cells ) but also in anchoragedependent fibroblasts. This is supported by a recent study in which syndecan-4 ligation was also shown to be required for FAK phosphorylation in anchorage-dependent fibroblasts .
How is syndecan-4 linked to FAK phosphorylation at the molecular level? Wade et al. (2002) showed that paxillin is required for the attachment-dependent phosphorylation of FAK in early cell spreading of ES cells while Denhez et al. (2002) demonstrated binding of paxillin to syndecan-4 through syndesmos. Thus paxillin might be crucial for integrin-and syndecan-4-mediated FAK activation, sequestering them into proximity within focal adhesions. This bridging function of paxillin may not take place in cells plated on the fibronectin/tenascin-C substratum. Our data are consistent with this possibility since tenascin-C blocks syndecan-4 ligation as well as recruitment of paxillin into focal adhesions, whereby FAK phosphorylation is prevented.
ECM-mediated cell spreading activates small GTPases which are involved in fibronectin matrix assembly and cell cycle progression (Danen and Yamada, 2001 ). Especially Rho is important for actin stress fiber formation (Hall, 1998) and fibronectin matrix assembly (Bourdoulous et al., 1998) . Since we observed that actin stress fiber formation and fibronectin matrix assembly (data not shown) on the fibronectin/ tenascin-C substratum was inhibited, we considered the possibility that Rho activation might be blocked. However, in contrast to a fibrin/fibronectin context (Wenk et al., 2000; Midwood and Schwarzbauer, 2002) , activation of Rho did not overcome a tenascin-Cspecific adhesion nor proliferation block (data not shown). Finally, Rho activation has been proposed to overcome the requirement of syndecan-4 for cell spreading and actin stress fiber formation (Saoncella et al., 1999) . This does not appear to apply to a fibronectin/tenascin-C context since constitutively active Rho did not restore cell spreading and actin stress fiber formation (data not shown). However, actin reorganization depends not only on Rho but is regulated at multiple levels (reviewed in Van Aelst and D'SouzaSchorey, 1997; Hall and Nobes, 2000; Petit and Thiery, 
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Tenascin-C blocks syndecan-4 and inhibits cdk2 G Orend et al 2000) . Our preliminary data revealed downregulation of tropomyosins, which bind actin fibrils (Boyd et al., 1995) , and colocalization of actin with fascin in REF52 cells on the fibronectin/tenascin-C substratum. This suggests that actin dynamics and stabilization of actin stress fibers might be affected by tenascin-C (Orend G, Huang W, Ruiz C, Fluri E, Adams JA and ChiquetEhrismann R, manuscript in preparation). Future experiments are needed to address how tenascin-C blocks actin stress fiber formation and/or stabilization in a fibronectin context.
It is well established that anchorage-dependent cells require integrin signaling for proliferation (Giancotti and Ruoslahti, 1999) . Recently, it was shown that 3T3-F442A mouse adipocytes also require syndecan-4 in order to proliferate since syndecan-4 antisense expression blocked DNA replication (Landry et al., 2001) . Our data support the notion that anchorage-dependent cells require syndecan-4 in addition to integrin signaling for proliferation. We extended this observation by showing that syndecan-4 ligation by fibronectin is required for cdk2 activation.
The finding that tenascin-C stimulates proliferation of tumor cells ) and blocks cell proliferation in anchorage-dependent cells underlines the importance of cell-matrix interactions for cell proliferation. In tumor cells competitive binding of tenascin-C to fibronectin blocks syndecan-4 in fibronectin-mediated adhesion signaling which relieves tumor cells from the attenuating effect of fibronectin on cell proliferation .
Inhibition of cdk2 by tenascin-C in normal cells demonstrates the importance of this complex in adhesion control of cell proliferation. This is particularly important with respect to malignant transformation, since cyclin E-cdk2 controls G1/S progression (Resnitzky and Reed, 1995) , centrosome duplication (Hinchcliffe et al., 1999) , maintenance of genomic stability (Spruck et al., 1999) and is deregulated in many tumor cells Slingerland and Pagano, 2000) . Further experiments are required to address the question of how tenascin-C uncouples tumor cells from the adhesion control of cyclin E-cdk2 function seen in anchorage-dependent cells.
In summary, we have shown that anchorage-dependent fibroblasts do not proliferate on immobilized tenascin-C, either alone or in combination with fibronectin. Our data suggest that depending on the context tenascin-C may induce different pathways to block cell proliferation in anchorage-dependent fibroblasts both resulting in inhibition of cdk2. Pure tenascin-C causes cell rounding and upregulation of the CKIs as previously described for artificial antiadhesive conditions (Miranti and Brugge, 2002) . In contrast, a mixed fibronectin and tenascin-C substratum interferes with cell adhesion on a more subtle level causing a defect in cell spreading through inactivation of syndecan-4 without increasing the CKI expression levels. Our results point to a crucial role for syndecan-4 not only in adhesion signaling, but also in the control of cell proliferation.
Materials and methods
Reagents
The following chemicals were obtained from Sigma (St Louis, MS, USA): soybean trypsin inhibitor, PDGF-BB, 100 Â ITS (10 mg/ml insulin, 5.5 mg/ml transferrin, 5 ng/ml selenium, 0.5 mg/ml BSA, 4.7 mg/ml oleic acid), heparin, histone H1 and BSA. Other reagents were purchased as indicated: DMEM and a-MEM (Gibco/Lifetechnologies, Paisley, Scotland), [ 3 H]thymidine (Moravek, Brea, CA, USA), precasted 4-20% Trisglycine gels (Invitrogen, Groningen, The Netherlands), FCS and horse serum (Bioconcept, Allschwil, Switzerland), protein A sepharose (Pharmacia, Wikstro¨m, Sweden).
Antibodies
The following antibodies were used for Western blotting and immunoprecipitation: anti-cyclin E (C19), cdk2 (M2), cdk4 (Santa Cruz Biotechnologies), anti-cyclin D (Upstate Biotechnologies), anti-p21Cip1 and p27Kip1 (Transduction Laboratories), anti-cyclin A (Tony Hunter, The Salk Institute, La Jolla, CA, USA) and mouse anti-syndecan-4 (8C7) (Guido David, University Leuven, Leuven, Belgium), mouse antivinculin (Sigma, St Louis, MS, USA), rabbit anti-FAK (Upstate Biotech., Lake Placid, NY, USA), rabbit antiphospho Y397 FAK (Biosource Int., Camarillo, CA, USA), mouse anti-phosphotyrosine (4G10), mouse anti-paxillin (Zymed Lab., San Francisco, CA, USA), anti-b1 integrin (Graus-Porta et al., 2001) , and goat anti-mouse and goat antirabbit FITC and TRITC-labeled secondary antibodies (Molecular Probes, Leiden, Netherlands).
Preparation of tenascin-C, fibronectin, FNIII13 and pep I
Chicken tenascin-C TN260 or TN190, horse fibronectin and FNIII13 were prepared as described previously . Pep I (RRARVTDATETTITISWRTK) corresponds to a 20 amino-acid sequence inside fibronectin (1697-1746) and was synthesized in-house.
Cell lines and cell culture
MRC-5, MRC-5 SV40, REF52, HS68 and NIH3T3 were originally obtained from ATCC; HDF cells were a gift from Hartmut Beug (IMP, Vienna, Austria). Pools of syndecan-4 overexpressing REF52 cells were obtained upon stable transfection of mouse syndecan-4 cDNA and selection with G418. Cells were cultured in DMEM or a-MEM with 10% FCS and antibiotics (0.36 mg/ml penicillin, 1 mg/ml streptomycin, 10 mg/ml gentamicin).
DNA replication assay
Microtiter plates were coated with ECM molecules to give 2 mg/cm 2 (fibronectin and tenascin-C) and 8 mg/cm 2 (FNIII13) unless indicated otherwise for 1 h at 371C. ECM proteins were coated separately, starting with fibronectin, followed by tenascin-C and FNIII13. Finally, the noncoated plastic surface was blocked with 1% heat-inactivated BSA in PBS. We confirmed that fibronectin was not replaced by the subsequent coating of tenascin-C by ELISA as well as by extracting the substratum-bound material and analysing it on SDS-PAGE. Before plating, cells were serum starved for 18 h in DMEM/ ITS and trypsinized. Trypsin was blocked with 100 mg/ml soybean trypsin inhibitor in PBS and cells were transferred onto the coated plates in the presence of the mitogens PDGF-BB (40 or 80 ng/ml) or a mixture of EGF (100 ng/ml), insulin (100 ng/ml), LPA (1 mm), PDGF-BB (80 ng/ml) and TGFb (0.5 nm) (EILPT 
Western blotting, immunoprecipitation and in vitro kinase assays
Aliquots of cells were lysed in RIPA (150 mm NaCl, 50 mm Tris-HCl pH 8, 1% NP40, 0.5% deoxycholic acid, 0.1% SDS, 50 mm NaF, 2 mm Na 3 VO 4 , protease inhibitors) for FAK analysis and in 0.1% NP40 buffer (50 mm Tris-HCl pH 7.5, 5 mm NaF, 250 mm NaCl, 5 mm EDTA, 0.1% NP40, protease inhibitors) for all other investigations. Equal protein amounts were subjected to immunoprecipitation, Western blotting and in vitro kinase assays. These assays were performed as described previously (Fang et al., 1996) . For detection of syndecan-4 core protein expression by Western blot, 50 mg of total cell lysate of REF52 and REF52:S4 were treated with bacterial heparitinase (2.5 IU) and chondroitinase (1 IU) for 4 h at 371C as described (Tumova et al., 2000) .
Immunofluorescence microscopy
Cells were plated and fixed as described . Briefly, cells were fixed with 4% paraformaldehyde in 50 mm phosphate buffer, 5 mm EDTA in PBS for 15 min, blocked with 3% BSA, 0.5% Tween-20 in PBS and incubated with TRITC-phalloidin, or primary and secondary antibodies in blocking solution. Slides were embedded in 10.5% Mowiol containing 2.5% DABCO as an antifade agent.
Abbreviations FCS, fetal calf serum; HDF, human diploid fibroblast; Cdk, cyclin-dependent kinase; ECM, extracellular matrix; EILPT, growth factor cocktail (EGF, insulin, LPA, PBGF-BB, TGFb); CKI, cyclin-dependent kinase inhibitor; FAK, focal adhesion kinase.
